Literature DB >> 32008361

Trajectories of fertility intentions among women living with HIV in South Africa.

Katherine B Rucinski1,2, Kimberly A Powers3, Audrey E Pettifor3, Vivian Black2,4, Brian W Pence3, Benjamin H Chi5, Helen Rees2, Sheree R Schwartz1,2.   

Abstract

Fertility intentions are thought to be dynamic among women of reproductive age, yet few studies have assessed fertility intentions over time among women with HIV. We examine temporal patterns of fertility intentions in women with HIV to assess the extent to which fertility intentions - and the corresponding need for safer conception and judicious antiretroviral therapy (ART) regimen selection - vary over time. 850 non-pregnant HIV-positive women aged 18-35 on or being initiated onto ART in Johannesburg, South Africa were enrolled into a prospective cohort study (2009-2010). Fertility intentions were assessed at enrollment and at 30-day intervals via an interviewer-administered questionnaire. We used group-based trajectory modelling to identify longitudinal patterns of fertility intentions over 12 months. We identified four patterns of fertility intentions, which we labelled "consistently low" (representing ∼60% of the population), "low and increasing" (∼23%), "high and increasing" (∼12%), and "high and decreasing" (∼5%). Our findings suggest that a single family-planning assessment at one time point is insufficient to fully identify and meet the reproductive needs of women with HIV. As HIV testing and treatment evolve in South Africa, routine screening for fertility intentions can offer important opportunities to optimize HIV treatment, prevention, and maternal and child health.

Entities:  

Keywords:  Fertility intentions; HIV/AIDS; dolutegravir; safer conception; women

Mesh:

Year:  2020        PMID: 32008361      PMCID: PMC7395884          DOI: 10.1080/09540121.2020.1719969

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  25 in total

1.  Group-based trajectory modeling in clinical research.

Authors:  Daniel S Nagin; Candice L Odgers
Journal:  Annu Rev Clin Psychol       Date:  2010       Impact factor: 18.561

2.  High pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy.

Authors:  Sheree R Schwartz; Shruti H Mehta; Taha E Taha; Helen V Rees; Francois Venter; Vivian Black
Journal:  AIDS Behav       Date:  2012-01

3.  Issues about periconception use of dolutegravir are reminiscent of early concerns about efavirenz.

Authors:  Vivian Black; Sheree R Schwartz
Journal:  Lancet HIV       Date:  2018-12       Impact factor: 12.767

4.  The time dynamics of individual fertility preferences among rural Ghanaian women.

Authors:  Ivy A Kodzi; John B Casterline; Peter Aglobitse
Journal:  Stud Fam Plann       Date:  2010-03

5.  Eliminating Bias in Classify-Analyze Approaches for Latent Class Analysis.

Authors:  Bethany C Bray; Stephanie T Lanza; Xianming Tan
Journal:  Struct Equ Modeling       Date:  2015-01       Impact factor: 6.125

6.  Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana.

Authors:  Rebecca Zash; Lewis Holmes; Modiegi Diseko; Denise L Jacobson; Sean Brummel; Gloria Mayondi; Arielle Isaacson; Sonya Davey; Judith Mabuta; Mompati Mmalane; Tendani Gaolathe; M Essex; Shahin Lockman; Joseph Makhema; Roger L Shapiro
Journal:  N Engl J Med       Date:  2019-07-22       Impact factor: 91.245

7.  Efavirenz conceptions and regimen management in a prospective cohort of women on antiretroviral therapy.

Authors:  Sheree Schwartz; Taha E Taha; Willem Daniel Francois Venter; Shruti Mehta; Helen Rees; Vivian Black
Journal:  Infect Dis Obstet Gynecol       Date:  2012-06-15

Review 8.  HIV and the risk of direct obstetric complications: a systematic review and meta-analysis.

Authors:  Clara Calvert; Carine Ronsmans
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

9.  Longitudinal patterns of unmet need for contraception among women living with HIV on antiretroviral therapy in South Africa.

Authors:  Katherine B Rucinski; Kimberly A Powers; Sheree R Schwartz; Brian W Pence; Benjamin H Chi; Vivian Black; Helen Rees; Audrey E Pettifor
Journal:  PLoS One       Date:  2018-12-20       Impact factor: 3.240

10.  Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception.

Authors:  Rebecca Zash; Joseph Makhema; Roger L Shapiro
Journal:  N Engl J Med       Date:  2018-07-24       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.